These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12410794)
1. DNA immunization of mice against the VP1 capsid protein of coxsackievirus B4. Toniolo A; Falcone V; Bernasconi C; Basolo F; Speziale P; Onodera T Scand J Immunol; 2002 Nov; 56(5):448-55. PubMed ID: 12410794 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471 [TBL] [Abstract][Full Text] [Related]
3. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge. Yin L; Chai D; Yue Y; Dong C; Xiong S Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849 [TBL] [Abstract][Full Text] [Related]
4. [C3d enhances immune response to the secreted form of Coxsackie virus B3 VP1 DNA vaccine]. Zhao N; Han XY; Wang XL; Li J; Li W; Xie LX; Li L; Wang YX Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2561-3. PubMed ID: 18067834 [TBL] [Abstract][Full Text] [Related]
5. [The effects of inoculation route and adjuvant type on the immunizing potency of CVB3 VP1 protein]. Wen C; Gao ZY; Lan JM; Yan LJ; Chuai X; Li J; Li W; Wang YX Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1086-9. PubMed ID: 21968309 [TBL] [Abstract][Full Text] [Related]
6. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination. Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097 [TBL] [Abstract][Full Text] [Related]
7. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Wu CN; Lin YC; Fann C; Liao NS; Shih SR; Ho MS Vaccine; 2001 Dec; 20(5-6):895-904. PubMed ID: 11738755 [TBL] [Abstract][Full Text] [Related]
8. [Immune effects of four coxsackievirus B3 VP1 DNA fusion vaccines in mice]. Liu GX; Lan JM; Chuai X; Gao ZY; Jin YH; Zhang YH; Xie LX; Yin CF; Wang YX Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):103-6. PubMed ID: 20230664 [TBL] [Abstract][Full Text] [Related]
9. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Chiu CH; Chu C; He CC; Lin TY Microbes Infect; 2006 Jun; 8(7):1671-8. PubMed ID: 16815726 [TBL] [Abstract][Full Text] [Related]
10. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362 [TBL] [Abstract][Full Text] [Related]
11. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus. Fan H; Tong T; Chen H; Guo A Virus Genes; 2007 Oct; 35(2):347-57. PubMed ID: 17497212 [TBL] [Abstract][Full Text] [Related]
12. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice. Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus. Yang NS; Wang JH; Lin KF; Wang CY; Kim SA; Yang YL; Jong MH; Kuo TY; Lai SS; Cheng RH; Chan MT; Liang SM J Gene Med; 2005 Jun; 7(6):708-17. PubMed ID: 15693054 [TBL] [Abstract][Full Text] [Related]
14. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment. Ch'ng WC; Stanbridge EJ; Ong KC; Wong KT; Yusoff K; Shafee N J Med Virol; 2011 Oct; 83(10):1783-91. PubMed ID: 21837796 [TBL] [Abstract][Full Text] [Related]
15. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1. Premanand B; Kiener TK; Meng T; Tan YR; Jia Q; Chow VT; Kwang J Antiviral Res; 2012 Sep; 95(3):311-5. PubMed ID: 22691220 [TBL] [Abstract][Full Text] [Related]
16. Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice. Henke A; Chiang CS; Zell R; Stelzner A Antiviral Res; 2004 Nov; 64(2):131-6. PubMed ID: 15498609 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643 [TBL] [Abstract][Full Text] [Related]
18. [Study on combined immunization of rAd/MDC-VP1 and pcDNA3/MDC-VP1 against Coxsackievirus B3 challenge in mice]. Yan LJ; Gao ZY; Li J; Lan JM; Jin YH; Xie LX; Chuai X; Wang YX Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):228-31. PubMed ID: 22394627 [TBL] [Abstract][Full Text] [Related]
19. Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization. Henke A; Wagner E; Whitton JL; Zell R; Stelzner A J Virol; 1998 Oct; 72(10):8327-31. PubMed ID: 9733878 [TBL] [Abstract][Full Text] [Related]
20. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice. Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]